<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="initial-scale=1, width=device-width" />

    <link rel="stylesheet" href="./global.css" />
    <link rel="stylesheet" href="./desktop-7.css" />
    <link
      rel="stylesheet"
      href="https://fonts.googleapis.com/css2?family=Mplus 1p:wght@400&display=swap"
    />
    <link
      rel="stylesheet"
      href="https://fonts.googleapis.com/css2?family=Lato:wght@400&display=swap"
    />
    <link
      rel="stylesheet"
      href="https://fonts.googleapis.com/css2?family=Inter:ital,wght@0,300;0,400;0,500;0,600;1,400&display=swap"
    />
  </head>
  <body>
    <div class="desktop-7">
      <div class="about-us1">About us :</div>
      <div class="hkd-cancer-immunotherapy-container">
        <p class="blank-line">
          HKD Cancer Immunotherapy Solutions Inc. is a pioneering company
          dedicated to advancing cancer immunotherapy through cutting-edge
          technology and innovative solutions. Founded by Miss H. K. Devda, the
          company is on a mission to revolutionize cancer treatment by
          harnessing the power of AI-technology integration.
        </p>
        <p class="blank-line">&nbsp;</p>
        <p class="blank-line">
          Our Vision: At HKD Cancer Immunotherapy Solutions Inc., we envision a
          world where cancer treatment is not just about fighting the disease
          but empowering patients with personalized, effective, and targeted
          therapies.Our Mission: Our mission is to provide state-of-the-art
          technology and solutions that enhance the effectiveness and
          accessibility of cancer immunotherapy. By leveraging AI technology
          integration, we aim to optimize treatment strategies, improve patient
          outcomes, and contribute to the ongoing evolution of cancer research
          and treatment protocols.
        </p>
        <p class="blank-line">&nbsp;</p>
        <p class="blank-line">
          Founder's Vision: Miss H. K. Devda, the visionary founder of HKD
          Cancer Immunotherapy Solutions Inc., brings a keen interest in the use
          of AI-technology integration to the forefront of cancer immunotherapy.
          Her passion for innovation and commitment to patient-centric care
          drive the company's initiatives towards developing transformative
          solutions for cancer patients worldwide.
        </p>
        <p class="blank-line">&nbsp;</p>
        <p class="blank-line">
          Through collaboration, research, and a deep understanding of the
          complexities of cancer biology, HKD Cancer Immunotherapy Solutions
          Inc. is dedicated to making significant strides in the fight against
          cancer. We are committed to driving progress, fostering partnerships,
          and ultimately making a positive impact on the lives of individuals
          affected by cancer.
        </p>
      </div>
      <div class="founder">Founder</div>
      <div class="desktop-7-child"></div>
      <div class="miss-hk-devda">Miss H.K Devda</div>
      <i class="miss-h-k"
        >“Miss H. K. Devda  demonstrates forward-thinking problem-solving
        abilities and exceptional leadership qualities, incorporating futuristic
        annotations to analyze and address challenges proactively.  She is
        dedicated to
      </i>
      <i class="dr-mary-roary-container">
        <p class="dr-mary-roary">- Dr Mary Roary </p>
        <p class="blank-line">
          (Chief Equity Officer of Behavioral Health Equity (OBHE) at the U.S.
          Department of Health and Human
        </p>
      </i>
      <img class="desktop-7-item" alt="" src="./public/vector-8.svg" />
    </div>
  </body>
</html>
